PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsLowest price public DNA testing launched in US

BioNews

Lowest price public DNA testing launched in US

Published 19 July 2009 posted in News and appears in BioNews 517

Author

Sarah Pritchard

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A venture-backed US start-up company ‘Pathway Genomics' announced its launch last week, and is promising to provide the most comprehensive DNA analysis publicly available; for the lowest price....

A venture-backed US start-up company ‘Pathway Genomics' announced its launch last week, and is promising to provide the most comprehensive DNA analysis publicly available; for the lowest price.


With some heavyweight investors such as technology firm ‘Founders Fund' backing them, Pathway, based in San Diego and formed in 2008, is offering consumers ancestry testing for $199 and DNA screening for $249.


Pathway have developed a ‘saliva collection kit' which will provide consumers with confidential information about their risk of developing more than 90 health conditions including several cancers, cardiovascular diseases, rheumatoid arthritis and Type 1 and Type 2 diabetes. In addition to details of inherited conditions, Pathway will for the first time be able to indicate risk factors for several drugs using their DNA screening process, and promises to be able to trace ancestry back more than 150,000 years.


Jim Plante, founder and Chief Executive Officer of Pathway Genomics who brings a decade of experience in technology and preventative health to the company has ‘brought together a seasoned group of entrepreneurs and marketing experts to launch Pathway Genomics'. Plante believes ‘it was the right time to put together a service like this. We see our clientele as people very interested in improving health and wellness'.


One of the reasons Pathway is able to provide its services at competitive prices is a government-approved onsite laboratory. State and federal endorsement ensures that the genetic information provided to consumers is confidential, accurate and reliable, and saliva samples never leave the company's grounds.


Pathway's Chief Scientific Officer is Dr David Becker, who is known for his contribution to Alzheimer's research, particularly his 2008 breakthrough discovery of certain gene variants that influence the risk of developing the condition.


‘Evaluating an individual's genetic profile is important, but it only reveals part of a person's health and wellness. The overall picture should also include information about a person's family history and lifestyle,' said Dr Becker. ‘For this reason, we want our consumers to take control of their health by identifying areas in their life that they could change to reduce their risk for developing diseases.'


For an extra fee, Pathway will provide customers and doctors with genetic counselling which will aim to use individuals ‘risk factor profiles' to inform how lifestyle, heredity and genetics combine to influence health.

Sources and References

  • 15/07/2009
    Pathway Genomics launches public DNA testing
  • 15/07/2009
    Wall Street Journal
    Start-ups bring genetic tests to the home
  • 15/07/2009
    Business Wire
    Pathway Genomics Brings Together Renowned Team of Entrepreneurs, Scientists, Physicians, and a Government Certified Lab to Offer Personal Genetics Services (press release)
  • 15/07/2009
    Technology Review
    More DNA for less

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 February 2011 • 2 minutes read

New genetic screening test for rare diseases to be launched in US

by Rosemary Paxman

A new genetic test screening for almost 450 rare childhood genetic diseases could be available in the US this year, reports the Beyond Batten Disease Foundation (BBDF)....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 February 2011 • 1 minute read

US Undiagnosed Diseases Program identifies new genetic condition

by Rosemary Paxman

The genetic basis for a previously unexplained medical condition which causes a painful hardening of the arteries has been identified by the US Undiagnosed Diseases Program (UDP)....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Most aren’t worried by Alzheimer’s gene risk test results, study shows

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels


easyfundraising
amazon

This month in News

  • Popular
  • Recent
20 November 2023 • 3 minutes read

HFEA publishes recommendations for reform of fertility law

13 November 2023 • 2 minutes read

Four BRCA mutation carriers undergo removal of ovaries during C-section 

13 November 2023 • 2 minutes read

Frequent mobile phone use linked to lower sperm count in young men

6 November 2023 • 3 minutes read

Health Council of the Netherlands recommends doubling the 14-day limit on embryo research

30 October 2023 • 2 minutes read

Government to scrap additional IVF screening for same-sex couples

27 November 2023 • 2 minutes read

Research into gene therapy reveals blood cancer risk

27 November 2023 • 2 minutes read

Polish Parliament debates reinstatement of state IVF funding

27 November 2023 • 2 minutes read

Over 100,000 DNA evidence samples must be re-tested in Australia

27 November 2023 • 2 minutes read

Childhood autism associated with infertility in parents

27 November 2023 • 2 minutes read

Unintended consequence of CRISPR/Cas9 genome editing discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856